186 related articles for article (PubMed ID: 32858121)
1. Regulators of G protein signalling as pharmacological targets for the treatment of neuropathic pain.
Doyen PJ; Beckers P; Brook GA; Hermans E
Pharmacol Res; 2020 Oct; 160():105148. PubMed ID: 32858121
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-associated regulation of RGS in astrocytes and putative implication in neuropathic pain.
Doyen PJ; Vergouts M; Pochet A; Desmet N; van Neerven S; Brook G; Hermans E
J Neuroinflammation; 2017 Oct; 14(1):209. PubMed ID: 29078779
[TBL] [Abstract][Full Text] [Related]
3. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
Karakoula A; Tovey SC; Brighton PJ; Willars GB
Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
[TBL] [Abstract][Full Text] [Related]
4. Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins.
Hendriks-Balk MC; Peters SL; Michel MC; Alewijnse AE
Eur J Pharmacol; 2008 May; 585(2-3):278-91. PubMed ID: 18410914
[TBL] [Abstract][Full Text] [Related]
5. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.
Taneja A; Della Pasqua O; Danhof M
Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907
[TBL] [Abstract][Full Text] [Related]
6. Regulator of G protein signaling proteins: novel multifunctional drug targets.
Zhong H; Neubig RR
J Pharmacol Exp Ther; 2001 Jun; 297(3):837-45. PubMed ID: 11356902
[TBL] [Abstract][Full Text] [Related]
7. Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.
Garzón J; Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P
Psychopharmacology (Berl); 2005 Jun; 180(1):1-11. PubMed ID: 15830230
[TBL] [Abstract][Full Text] [Related]
8. Targeting G protein-coupled receptors for the treatment of chronic pain in the digestive system.
Gottesman-Katz L; Latorre R; Vanner S; Schmidt BL; Bunnett NW
Gut; 2021 May; 70(5):970-981. PubMed ID: 33272979
[TBL] [Abstract][Full Text] [Related]
9. Regulators of G-protein-signaling proteins: negative modulators of G-protein-coupled receptor signaling.
Woodard GE; Jardín I; Berna-Erro A; Salido GM; Rosado JA
Int Rev Cell Mol Biol; 2015; 317():97-183. PubMed ID: 26008785
[TBL] [Abstract][Full Text] [Related]
10. Introduction: G Protein-coupled Receptors and RGS Proteins.
Stewart A; Fisher RA
Prog Mol Biol Transl Sci; 2015; 133():1-11. PubMed ID: 26123299
[TBL] [Abstract][Full Text] [Related]
11. Regulator of G-protein signalling and GoLoco proteins suppress TRPC4 channel function via acting at Gαi/o.
Jeon JP; Thakur DP; Tian JB; So I; Zhu MX
Biochem J; 2016 May; 473(10):1379-90. PubMed ID: 26987813
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts.
Liebmann C
Curr Pharm Des; 2004; 10(16):1937-58. PubMed ID: 15180530
[TBL] [Abstract][Full Text] [Related]
13. Adenosine receptor signalling: Probing the potential pathways for the ministration of neuropathic pain.
Shaw S; Uniyal A; Gadepalli A; Tiwari V; Belinskaia DA; Shestakova NN; Venugopala KN; Deb PK; Tiwari V
Eur J Pharmacol; 2020 Dec; 889():173619. PubMed ID: 33011242
[TBL] [Abstract][Full Text] [Related]
14. Regulators of G-protein signalling as new central nervous system drug targets.
Neubig RR; Siderovski DP
Nat Rev Drug Discov; 2002 Mar; 1(3):187-97. PubMed ID: 12120503
[TBL] [Abstract][Full Text] [Related]
15. Regulators of G protein signalling: potential targets for treatment of allergic inflammatory diseases such as asthma.
Druey KM
Expert Opin Ther Targets; 2003 Aug; 7(4):475-84. PubMed ID: 12885267
[TBL] [Abstract][Full Text] [Related]
16. Regulators of G-protein signaling in the heart and their potential as therapeutic targets.
Zhang P; Mende U
Circ Res; 2011 Jul; 109(3):320-33. PubMed ID: 21778436
[TBL] [Abstract][Full Text] [Related]
17. Multi-tasking RGS proteins in the heart: the next therapeutic target?
Riddle EL; Schwartzman RA; Bond M; Insel PA
Circ Res; 2005 Mar; 96(4):401-11. PubMed ID: 15746448
[TBL] [Abstract][Full Text] [Related]
18. Regulators of G protein signaling (RGS proteins): novel central nervous system drug targets.
Neubig RR
J Pept Res; 2002 Dec; 60(6):312-6. PubMed ID: 12464108
[TBL] [Abstract][Full Text] [Related]
19. Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials.
O'Brien JB; Wilkinson JC; Roman DL
J Biol Chem; 2019 Dec; 294(49):18571-18585. PubMed ID: 31636120
[TBL] [Abstract][Full Text] [Related]
20. Regulators of G protein signaling proteins as central components of G protein-coupled receptor signaling complexes.
McCoy KL; Hepler JR
Prog Mol Biol Transl Sci; 2009; 86():49-74. PubMed ID: 20374713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
